Obesity, NASH, RA deals among J&J's latest partnerships

The Johnson & Johnson Innovation unit of Johnson & Johnson (NYSE:JNJ) announced several partnerships, including collaborations concerning obesity, non-alcoholic steatohepatitis and rheumatoid arthritis.

J&J's Janssen Pharmaceuticals Inc. unit partnered with

Read the full 296 word article

User Sign In